Business Description
Ascelia Pharma AB
ISIN : SE0010573113
Compare
Compare
Traded in other countries / regions
ACE.Sweden7ZA.GermanyACEs.UK IPO Date
2020-12-10Description
Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo Sweden focused on orphan oncology It develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway The company has two drug candidates Orviglance and Oncoral in clinical development.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.41 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | -0.21 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 5 | |||||
3-Year EPS without NRI Growth Rate | 5.1 | |||||
3-Year FCF Growth Rate | -4.8 | |||||
3-Year Book Growth Rate | -35.9 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.59 | |||||
9-Day RSI | 43.22 | |||||
14-Day RSI | 45.7 | |||||
6-1 Month Momentum % | 96.21 | |||||
12-1 Month Momentum % | -40.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.05 | |||||
Quick Ratio | 3.05 | |||||
Cash Ratio | 2.37 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.2 | |||||
Shareholder Yield % | -1.51 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -94 | |||||
ROA % | -73.34 | |||||
ROIC % | -118.96 | |||||
ROC (Joel Greenblatt) % | -6616.98 | |||||
ROCE % | -90.68 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4.95 | |||||
Price-to-Tangible-Book | 77.6 | |||||
EV-to-EBIT | -3.32 | |||||
EV-to-Forward-EBIT | -3.27 | |||||
EV-to-EBITDA | -3.32 | |||||
EV-to-Forward-EBITDA | -3.27 | |||||
EV-to-FCF | -2.91 | |||||
Price-to-Net-Current-Asset-Value | 77.6 | |||||
Earnings Yield (Greenblatt) % | -30.12 | |||||
FCF Yield % | -34.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ascelia Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.226 | ||
Beta | 0.94 | ||
Volatility % | 232.36 | ||
14-Day RSI | 45.7 | ||
14-Day ATR (€) | 0.03605 | ||
20-Day SMA (€) | 0.7955 | ||
12-1 Month Momentum % | -40.67 | ||
52-Week Range (€) | 0.1658 - 1.376 | ||
Shares Outstanding (Mil) | 33.76 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ascelia Pharma AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ascelia Pharma AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Ascelia Pharma AB Frequently Asked Questions
What is Ascelia Pharma AB(FRA:7ZA)'s stock price today?
The current price of FRA:7ZA is €0.78. The 52 week high of FRA:7ZA is €1.38 and 52 week low is €0.17.
When is next earnings date of Ascelia Pharma AB(FRA:7ZA)?
The next earnings date of Ascelia Pharma AB(FRA:7ZA) is 2024-08-15.
Does Ascelia Pharma AB(FRA:7ZA) pay dividends? If so, how much?
Ascelia Pharma AB(FRA:7ZA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |